Idylla™ MSI Test

Primary DI
15415219000758
Brand
Idylla™ MSI Test
Company
Biocartis NV
Model
2
Device description
The Idylla MSI Test, for use on the Idylla System, uses formalin-fixed, paraffin embedded (FFPE) tissue sections of human CRC tumor, from which nucleic acids are liberated, then analyzed using PCR amplification of seven monomorphic biomarkers (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A and SULF2) and subsequent melt-curve analysis. The Idylla MSI Test reports results as either microsatellite stable (MSS), or microsatellite instability high (MSI-H) or invalid.
Published
2023-05-03
Public version status
New
Distribution status
In Commercial Distribution
MRI safety
Labeling does not contain MRI Safety Information
Rx
true
Single use
true

Product Codes#

Code, Name table
CodeName
PZJLynch Syndrome Test System

Product Code Classifications#

Code, Device, Specialty table
CodeDeviceSpecialtyClass
PZJLynch Syndrome Test SystemImmunology2

Premarket Submissions#

Submission, Supplement table
SubmissionSupplement
K211181000

Premarket Details#

Submission, Supplement, Device table
SubmissionSupplementDeviceApplicantDecision dateProduct code
K211181000Idylla MSI TestBiocartis NV2023-02-27PZJ

Identifiers And Packaging#

Identifier, Type, Agency table
IdentifierTypeAgencyPackage quantityStatus
15415219000758PrimaryGS10
05415219000751Unit of UseGS10

Alternate GTIN / UPC / EAN Codes

Source identifier, GTIN-14 normalized, EAN-13 table
Source identifierGTIN-14 normalizedEAN-13
1541521900075815415219000758
05415219000751054152190007515415219000751

GMDN Terms#

Term, Definition table
TermDefinition
Microsatellite instability IVD, kit, nucleic acid technique (NAT)A collection of reagents and other associated materials intended to be used for determining microsatellite instability [abnormal repeated sequences of deoxyribonucleic acid (DNA)] within a tumour tissue specimen, using a nucleic acid technique (NAT). This phenomenon which is associated with defective DNA mismatch repair genes is a feature of certain cancer types including hereditary nonpolyposis colon cancer (HNPCC).

Sterilization Methods#

Method table
Method

Regulatory Flags#

DUNS number
400686169
Device count
6
Kit
true
Lot or batch
true
Expiration date on label
true

Other Devices From This Company#

Primary DI, Brand, Model table
Primary DIBrandModelCatalogPublished
15415219001328Idylla CDx MSI Testv32025-11-01
05415219000119Idylla™ SystemIdylla™ InstrumentP00102017-08-21
05415219000126Idylla™ SystemIdylla™ ConsoleP10102017-08-21
15415219000635Idylla™ Respiratory (IFV-RSV) Panel1.0A1030/62018-10-23

Other Devices Sharing Product Codes#

Primary DI, Brand, Company table
Primary DIBrandCompanyProduct codePublished
05055331335906BONDLEICA BIOSYSTEMS NEWCASTLE LTDPZJ2023-03-03
05055331335920BONDLEICA BIOSYSTEMS NEWCASTLE LTDPZJ2023-03-03
05055331336002BONDLEICA BIOSYSTEMS NEWCASTLE LTDPZJ2023-03-03
05055331336019BONDLEICA BIOSYSTEMS NEWCASTLE LTDPZJ2023-03-03
00849811056857OncoMate MSI Dx Interpretive SoftwarePROMEGA CORPORATIONPZJ2021-10-08
00849811056864OncoMate MSI Dx Assay InstallerPROMEGA CORPORATIONPZJ2021-10-08
00849811031717OncoMate MSI Dx Analysis SystemPROMEGA CORPORATIONPZJ2021-09-30
00849811050619OncoMate 5C Matrix StandardPROMEGA CORPORATIONPZJ2021-09-30
07613336100561VENTANA ANTI-MLH1 (M1) Mouse Monoclonal Primary AntibodyVentana Medical Systems, Inc.PZJ2018-02-08
07613336100578VENTANA Anti MSH6 (SP93) Rabbit Monoclonal Primary AntibodyVentana Medical Systems, Inc.PZJ2018-02-08
07613336100585VENTANA Anti MSH2 (G219-1129) Mouse Monoclonal Primary AntibodyVentana Medical Systems, Inc.PZJ2018-02-08
07613336100592VENTANA Anti-PMS2 (A16-4) Mouse Monoclonal Primary AntibodyVentana Medical Systems, Inc.PZJ2018-02-08
07613336100608VENTANA Anti-BRAF V600E (VE1) Mouse Monoclonal Primary AntibodyVentana Medical Systems, Inc.PZJ2018-02-08